Therefore, we need to use modern advanced biotechnology to optimize the molecular structure of LAG-3 inhibitors, clarify the functional and molecular mechanism characteristics of LAG-3 in more detail, and design more reasonable LAG-3 targeted therapy for various malignant tumors. The gene discussed is LAG3; the disease is cancer.